Table of Contents
Molecular Biology International
Volume 2015, Article ID 638515, 6 pages
http://dx.doi.org/10.1155/2015/638515
Research Article

FOXO3a Gene Polymorphism Associated with Asthma in Indian Population

Department of Biotechnology, Sinhgad College of Engineering, Vadgaon Budruk, Pune, Maharashtra 411041, India

Received 25 September 2015; Revised 24 November 2015; Accepted 25 November 2015

Academic Editor: Malayannan B. Subramaniam

Copyright © 2015 Shravani Barkund et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Bijanzadeh, P. A. Mahesh, and N. B. Ramachandra, “An understanding of the genetic basis of asthma,” Indian Journal of Medical Research, vol. 134, no. 2, pp. 149–161, 2011. View at Google Scholar · View at Scopus
  2. P. J. Barnes, “Immunology of asthma and chronic obstructive pulmonary disease,” Nature Reviews Immunology, vol. 8, no. 3, pp. 183–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Martin, D. Ohayon, and V. Witko-Sarsat, “Promoting apoptosis of neutrophils and phagocytosis by macrophages: novel strategies in the resolution of inflammation,” Swiss Medical Weekly, vol. 145, Article ID w14056, 2015. View at Publisher · View at Google Scholar
  4. D. Gibeon and A. N. Menzies-Gow, “Targeting interleukins to treat severe asthma,” Expert Review of Respiratory Medicine, vol. 6, no. 4, pp. 423–439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Jindall, “Asthma control in the first decade of 21st century,” Indian Journal of Medical Research, vol. 125, no. 5, pp. 604–607, 2007. View at Google Scholar · View at Scopus
  6. A. N. Aggarwal, K. Chaudhry, S. K. Chhabra et al., “Prevalence and risk factors for bronchial asthma in Indian adults: a multicentre study,” The Indian Journal of Chest Diseases & Allied Sciences, vol. 48, no. 1, pp. 13–22, 2006. View at Google Scholar · View at Scopus
  7. I. Tikhanovich, J. Cox, and S. A. Weinman, “Forkhead box class O transcription factors in liver function and disease,” Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 125–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Weigel, G. Jürgens, F. Küttner, E. Seifert, and H. Jäckle, “The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo,” Cell, vol. 57, no. 4, pp. 645–658, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Huang and D. J. Tindall, “Dynamic FoxO transcription factors,” Journal of Cell Science, vol. 120, no. 15, pp. 2479–2487, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-M. Bao, X.-L. Song, Y.-Q. Hong et al., “Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis,” Asian Journal of Andrology, vol. 16, no. 3, pp. 446–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. K. C. Arden, “Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer,” Experimental Gerontology, vol. 41, no. 8, pp. 709–717, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Boccitto and R. G. Kalb, “Regulation of Foxo-dependent transcription by post-translational modifications,” Current Drug Targets, vol. 12, no. 9, pp. 1303–1310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Kikuno, H. Shiina, S. Urakami et al., “Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity,” Oncogene, vol. 26, no. 55, pp. 7647–7655, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Wang, L. Zhou, J. Chen et al., “Association of the 3′UTR FOXO3a polymorphism rs4946936 with an increased risk of childhood acute lymphoblastic leukemia in a Chinese population,” Cellular Physiology and Biochemistry, vol. 34, no. 2, pp. 325–332, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S. K. Watkins and A. A. Hurwitz, “A master switch for regulating tolerance and immunity in dendritic cells,” OncoImmunology, vol. 1, no. 2, pp. 252–254, 2012. View at Publisher · View at Google Scholar
  16. J. C. Lee, M. Espéli, C. A. Anderson et al., “Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway,” Cell, vol. 155, no. 1, pp. 57–69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Xia and Y. Zhu, “FOXO3a involvement in the release of TNF-α stimulated by ATP in spinal cord astrocytes,” Journal of Molecular Neuroscience, vol. 51, no. 3, pp. 792–804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Nathan and A. Ding, “Nonresolving inflammation,” Cell, vol. 140, no. 6, pp. 871–882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Conti, G. Corbi, V. Manzo, G. Pelaia, A. Filippelli, and A. Vatrella, “Sirtuin 1 and aging theory for chronic obstructive pulmonary disease,” Analytical Cellular Pathology, vol. 2015, Article ID 897327, 8 pages, 2015. View at Publisher · View at Google Scholar
  20. L. Lin, J. D. Hron, and S. L. Peng, “Regulation of NF-κB, th activation, and autoinflammation by the forkhead transcription factor FOXO3a,” Immunity, vol. 21, no. 2, pp. 203–213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kalemci, T. G. Edgunlu, U. Ö. Turkcu, E. S. Çetin, A. Zeybek, and H. Candan, “FOXO3a gene polymorphism and serum FOXO3a levels in patients with chronic obstructive pulmonary disease and healthy controls: effects of genetic polymorphism in chronic obstructive pulmonary disease,” Smyrna Medical Journal, no. 1, 2014, http://www.smyrnatipdergisi.com/dosyalar_upload/belgeler/FOXO3a1414588072.pdf. View at Google Scholar
  22. J. Ludikhuize, D. de Launay, D. Groot et al., “Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue,” Arthritis & Rheumatism, vol. 56, no. 7, pp. 2180–2191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Snoeks, C. R. Weber, K. Wasland et al., “Tumor suppressor FOXO3 participates in the regulation of intestinal inflammation,” Laboratory Investigation, vol. 89, no. 9, pp. 1053–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. American Medical Association, International Classification of Diseases: Physician ICD-9-CM, vol. 1-2 of Revision 9, AMA Press, Chicago, Ill, USA, 2005.
  25. R. S. Nho and P. Hergert, “FoxO3a and disease progression,” World Journal of Biological Chemistry, vol. 5, no. 3, pp. 346–354, 2014. View at Publisher · View at Google Scholar
  26. U. Sela, M. Dayan, R. Hershkoviz, L. Cahalon, O. Lider, and E. Mozes, “The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responses,” European Journal of Immunology, vol. 36, no. 11, pp. 2971–2980, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Stahl, P. F. Dijkers, G. J. P. L. Kops et al., “The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2,” The Journal of Immunology, vol. 168, no. 10, pp. 5024–5031, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Möller, J. Alfredsson, M. Engström et al., “Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim,” Blood, vol. 106, no. 4, pp. 1330–1336, 2005. View at Publisher · View at Google Scholar · View at Scopus